Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Scope of Study
3.2 Research Objective
3.3 List of Assumptions
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Increasing demand for natural medicines
5.2.2 Increasing research funding for herbal medicines
5.2.3 Multiple applications of herbal medicines
5.3 Restraints
5.3.1 Side-effects and allergic reactions
5.3.2 Poor standardization
5.4 Opportunity
5.4.1 Relatively untapped markets of the Asia-Pacific region
6 Market Factor Analysis
6.1 Value Chain Analysis
6.1.1 Overview
6.1.2 R&D
6.1.3 Manufacturing
6.1.4 Distribution & Sales
6.1.5 Post-Sales Monitoring
6.2 Porter's Five Forces Model
6.2.1 Overview
6.2.2 Threat of New Entrants
6.2.3 Bargaining Power of Suppliers
6.2.4 Threat of Substitutes
6.2.5 Bargaining Power of Buyers
6.2.6 Intensity of Rivalry
7 Global Herbal Medicine Market, by Category
7.1 Introduction
7.2 Herbal Pharmaceuticals
7.3 Herbal Functional Foods
7.4 Herbal Beauty Products
7.5 Herbal Dietary Supplements
8 Global Herbal Medicine Market, by Type of Medicinal Plants
8.1 Introduction
8.2 Marrubium vulgare
8.3 Vaccinium macrocarpon
8.4 EChinacea
8.5 Curcuma longa
8.6 Camellia sinensis
8.7 Actaea racemose
8.8 Aloe vera
8.9 Zingiber officinale
8.1 Cocos nucifera
8.11 Cinnamomum spp
9 Global Herbal Medicine Market, by Form
9.1 Introduction
9.2 Extracts
9.3 Powders
9.4 Capsules & Tablets
9.5 Syrups
10 Global Herbal Medicine Market, by Source
10.1 Introduction
10.2 Leaves
10.3 Root & Barks
10.4 Whole Plants
10.5 Fruits
11 Global Herbal Medicine Market, By Distribution Channel
11.1 Introduction
11.2 Hospital & Retail Pharmacies
11.3 E-Commerce
12 Global Herbal Medicine Market, by Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.1.1 US
12.2.1.2 Canada
12.2.2 South America
12.3 Europe
12.3.1 Western Europe
12.3.1.1 Germany
12.3.1.2 U.K
12.3.1.3 France
12.3.1.4 Italy
12.3.1.5 Spain
12.3.1.6 Rest of Western Europe
12.3.2 Eastern Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 South Korea
12.4.6 Indonesia
12.4.7 Rest of Asia-Pacific
12.5 Middle East & Africa
12.5.1 Middle East
12.5.2 Africa
13 Competitive Landscape
14 Company Profiles
14.1 Arkopharma
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products/Services Offered
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Bayer AG
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products/Services Offered
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 BEOVITA
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products/Services Offered
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Hishimo Pharmaceuticals
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products/Services Offered
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Schaper & Br?mmer
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products/Services Offered
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 ZeinPharma Germany GmbH
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products/Services Offered
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 Venus Pharma GmbH
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products/Services Offered
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 Dasherb Corp.
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products/Services Offered
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Arizona Natural Products
14.9.1 Company Overview
14.9.2 Products/Services Offered
14.9.3 Key Developments
14.9.4 SWOT Analysis
14.9.5 Key Strategy
14.1 Blackmores
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products/Services Offered
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 Himalaya Global Holdings Ltd.
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products/Services Offered
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
14.12 Dr. Willmar Schwabe India Pvt. Ltd.
14.12.1 Company Overview
14.12.2 Financial Overview
14.12.3 Products/Services Offered
14.12.4 Key Developments
14.12.5 SWOT Analysis
14.12.6 Key Strategy
15 Appendix
15.1 Discussion Blue Print